Boehringer Ingelheim

Companies Boehringer Ingelheim

News Boehringer Ingelheim

• Horizon and Boehringer Ingelheim enter oncology research service collaboration

  Horizon Discovery Ltd announced it has signed a research service collaboration agreement with Boehringer Ingelheim. Horizon will support Boehringer Ingelheim’s oncology programs by using its Discovery Toolbox for research projects and profiling of compounds at the hit-to-lead, lead optimization and more

• Zealand Pharma advances ZP2929 into Phase I development for the treatment of Type 2 diabetes and/or obesity

  Zealand Pharma A/S announced that the first participant has been dosed in the first Phase I clinical study of ZP2929. ZP2929 is a dual acting glucagon/GLP-1 peptide agonists, invented by Zealand Pharma and with global rights out-licensed to Boehringer Ingelheim as part of a global license and resear more

• Nanobody for Alzheimer's disease moves closer toward phase I clinical trial

  Ablynx announced that Boehringer Ingelheim has submitted a Clinical Trials Application (CTA)  to the European regulatory authorities to start a Phase I clinical trial with a Nanobody® for the treatment of Alzheimer's disease. The Nanobody has been developed as part of the collaboration signed betwee more

Publications Boehringer Ingelheim

• Sensory transduction, the gateway to perception: mechanisms and pathology

  Sensory transduction, the gateway to perception: mechanisms and pathology EMBO Reports 12, 292 (2011). doi:10.1038/embor.2011.45 Authors: Stefan G Lechner & Jan Siemens The 102nd biannual Boehringer Ingelheim Fonds International Titisee Conference took place in October 2010. more

Market studies Boehringer Ingelheim

• Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020

  Introduction GlobalData, the industry analysis specialist, has released its new report, “Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020”. The report is an essential source of information and analysis on the global type 2 diabetes therapeutics market. The report provides comp more

• Global Active Pharmaceutical Ingredients Market 2011-2015

  TechNavio's analysts forecast the Global Active Pharmaceutical Ingredient market to grow at a CAGR of 7.9 percent over the period 2011-2015. One of the key factors contributing to this market growth is the entry of novel formulation technologies. The Global Active Pharmaceutical Ingredient market ha more

• Belgium Pharmaceuticals and Healthcare Report Q3 2012

  BMI View: Belgium’s rapidly ageing population, traditionally high per capita consumption of medicines and a well-developed healthcare system will combine to continue providing substantial commercial opportunities for pharmaceutical sector players. However, given the need for fiscal austerities in re more

Websites Boehringer Ingelheim